Acute Myeloid Leukemia /Features

ISAL 2017: Developments in acute leukemias

The International Symposium on Acute Leukemias (ISAL) 2017 was, as always, filled with data, scientific developments and debate. To capture…

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia
1 year

Innovative Medicines Initiative approves €40 million HARMONY project for better care of patients with hematologic malignancies

The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients…

Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma Myelodysplastic Syndromes Non-Hodgkin Lymphoma
2 years

New tyrosine kinase inhibitor shows promise

MRX-2843 is a tyrosine kinase inhibitor that targets the receptor tyrosine kinases MERTK and FLT3. Both MERTK and FLT3 are…

Acute Myeloid Leukemia
2 years

Cytarabine-daunorubicin liposome for injection: a potential new standard of care for elderly patients

The Phase III trial of a novel formulation of cytarabine-daunorubicin encapsulated in a liposome for injection, also referred to as…

Acute Myeloid Leukemia
2 years
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals